Phathom Pharmaceuticals Files Petition with FDA to Extend Exclusivity for VOQUEZNA Tablets
Phathom Pharmaceuticals, Inc. a biopharmaceutical company focused on advancing novel treatments for gastrointestinal (GI) diseases, has taken a decisive step to protect its innovative drug, VOQUEZNA (vonoprazan), by sub...
Dec 30, 2024
• Major Pharmaceutical Preparations Industry
Product Service News
Inc A Matthew Caufield Phathom Pharmaceuticals Inc